Recent med-tech developments include regulatory designations and market performance shifts. Cryofocus received FDA breakthrough device designation for its asthma cryoablation system, prompting stock gains. Boston Scientific reported a 117% growth in U.S. sales for its Farapulse pulsed field ablation system, improving overall cardiology revenue and tariff impact. The European Commission approved a €403 million fund to support digital and AI-enhanced medical devices, targeting 10 innovative companies. Regulatory and clinical trial snapshots reflect ongoing approvals and submissions across multiple companies such as AI Medical Service, Geneoscopy, and Minnesota Medical Tech, underscoring active innovation in the med-tech sector.